Literature DB >> 2255768

The effect of magnesium sulfate infusion on systemic and renal prostacyclin production.

W F O'Brien1, M C Williams, R Benoit, S K Sawai, R A Knuppel.   

Abstract

Recent in vitro studies have suggested that magnesium sulfate (MgSO4) infusions may increase prostacyclin production. We studied the effect of MgSO4 infusion on prostacyclin (PGI2) metabolite excretion in women with either pregnancy induced hypertension or preterm labor. Excretion of renal and systemic metabolites of PGI2 was measured prior to and following the start of MgSO4 infusion in the two groups. An increased in renal PGI2 metabolite preterm labor excretion was noted in the hypertension group but no change was noted in systemic PGI2 excretion in either group. These data fail to support a generalized, short term increase in endothelial cell PGI2 production as the basis for the beneficial effect of MgSO4.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2255768     DOI: 10.1016/0090-6980(90)90114-b

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  4 in total

Review 1.  Magnesium for neuroprotection in ischaemic stroke: rationale for use and evidence of effectiveness.

Authors:  K W Muir
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Magnesium causes nitric oxide independent coronary artery vasodilation in humans.

Authors:  H Teragawa; M Kato; T Yamagata; H Matsuura; G Kajiyama
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

3.  Prostacyclin and thromboxane levels in women with severe preeclampsia undergoing magnesium sulfate therapy during antepartum and postpartum periods.

Authors:  Yuping Wang; Yanping Zhang; Bernard J Canzoneri; Yang Gu; Lisa Philibert; David F Lewis
Journal:  Hypertens Pregnancy       Date:  2008       Impact factor: 2.108

4.  Magnesium sulfate has sex-specific, dose-dependent vasodilator effects on preterm placental vessels.

Authors:  Clint Gray; Mark H Vickers; Rebecca M Dyson; Clare M Reynolds; Mary J Berry
Journal:  Biol Sex Differ       Date:  2015-11-04       Impact factor: 5.027

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.